
The EHR Dark Data Goldmine: Why Sentence-Level Provenance Is Pharma's New Real-World Evidence Moat
Dr. Dereck Mush, MD, MBAProviding a neurological data platform to support therapy development and patient care.
The company offers a software platform that aggregates brain data from consumer wearables, implanted devices, and clinical assessments. Neurologists and pharmaceutical developers use this data to track disease progression and optimize therapies for patients with Parkinson's disease.
Notable investors: Eclipse Ventures, DigiTx Partners, TruVenturo.

Dr. Dereck Mush, MD, MBA
Dr. Dereck Mush, MD, MBA
Dr. Dereck Mush, MD, MBA
Dr. Dereck Mush, MD, MBA